Showing results (111-120 of 2,556) with videos related to
Sort By:
Pageof 256
Therapeutics and Clinical Risk Management|August 28, 2020
The Effect of 0.01% Atropine Eye Drops on the Ocular Surface in Children for the Control of Myopia-The Primary Results from a Six-Month Prospective StudyJingyi Cheng, Yujing Yang, Xiehe Kong, et al.Therapeutics and Clinical Risk Management|January 14, 2021
Computed Tomography Angiography of Gastrocolic Vein Trunk by Morphological Filtering Technique in Right Colon CancerLei Gu, Siyuan Wen, Chunjie Xu, et al.Therapeutics and Clinical Risk Management|January 14, 2021
Clinical Features for Severely and Critically Ill Patients with COVID-19 in Shandong: A Retrospective Cohort StudyShengyu Zhou, Jiawei Xu, Wenqing Sun, et al.Therapeutics and Clinical Risk Management|January 5, 2026
Electroacupuncture as a Non-Pharmacological Intervention for Nicotine Dependence: Evidence from a Randomized Clinical TrialZhen Lai, Qian Fan, Ai Ling Lee, et al.Therapeutics and Clinical Risk Management|January 5, 2026
Safety and Efficacy of Intra-Osseous versus Intravenous Vascular Access for Out-of-Hospital Cardiac Arrest: A Systematic Review and Meta-AnalysisMengjie Cai, Yu DaiTherapeutics and Clinical Risk Management|May 20, 2008
A review of the role of capecitabine in the treatment of colorectal cancerPasquale ComellaTherapeutics and Clinical Risk Management|May 20, 2008
Recombinant human epoetin beta in the treatment of renal anemiaFrancesco Locatelli, Pietro Pozzoni, Lucia Del VecchioTherapeutics and Clinical Risk Management|May 20, 2008
The safety and efficacy of alefacept in the treatment of chronic plaque psoriasisClaudia Jenneck, Natalija NovakTherapeutics and Clinical Risk Management|May 20, 2008
Treatment of community-acquired pneumonia, with special emphasis on gemifloxacinSerkan OncüTherapeutics and Clinical Risk Management|May 20, 2008
Rasagiline - a novel MAO B inhibitor in Parkinson's disease therapyShimon Lecht, Simon Haroutiunian, Amnon Hoffman, et al.Pageof 256